Dimensional Fund Advisors LP Boosts Stock Position in Fresenius Medical Care AG (NYSE:FMS)

Dimensional Fund Advisors LP raised its stake in Fresenius Medical Care AG (NYSE:FMS - Free Report) by 86.7% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 22,820 shares of the company's stock after purchasing an additional 10,600 shares during the quarter. Dimensional Fund Advisors LP's holdings in Fresenius Medical Care were worth $517,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Venturi Wealth Management LLC boosted its stake in shares of Fresenius Medical Care by 8.4% in the 4th quarter. Venturi Wealth Management LLC now owns 5,700 shares of the company's stock worth $129,000 after buying an additional 441 shares during the last quarter. PNC Financial Services Group Inc. boosted its stake in shares of Fresenius Medical Care by 5.0% in the 4th quarter. PNC Financial Services Group Inc. now owns 9,278 shares of the company's stock worth $210,000 after buying an additional 442 shares during the last quarter. Smartleaf Asset Management LLC boosted its stake in shares of Fresenius Medical Care by 192.8% in the 4th quarter. Smartleaf Asset Management LLC now owns 1,224 shares of the company's stock worth $28,000 after buying an additional 806 shares during the last quarter. DAVENPORT & Co LLC boosted its stake in shares of Fresenius Medical Care by 1.5% in the 4th quarter. DAVENPORT & Co LLC now owns 58,147 shares of the company's stock worth $1,316,000 after buying an additional 862 shares during the last quarter. Finally, Signaturefd LLC boosted its stake in shares of Fresenius Medical Care by 16.6% in the 4th quarter. Signaturefd LLC now owns 7,393 shares of the company's stock worth $167,000 after buying an additional 1,052 shares during the last quarter. 8.37% of the stock is owned by hedge funds and other institutional investors.

Fresenius Medical Care Stock Performance

Fresenius Medical Care stock traded down $0.50 during trading on Thursday, hitting $29.30. The stock had a trading volume of 569,674 shares, compared to its average volume of 329,383. Fresenius Medical Care AG has a 1 year low of $17.93 and a 1 year high of $30.46. The company has a quick ratio of 1.02, a current ratio of 1.37 and a debt-to-equity ratio of 0.42. The stock's 50 day moving average is $25.44 and its two-hundred day moving average is $23.94. The stock has a market cap of $17.20 billion, a price-to-earnings ratio of 24.22, a price-to-earnings-growth ratio of 0.76 and a beta of 0.85.

Fresenius Medical Care (NYSE:FMS - Get Free Report) last posted its quarterly earnings data on Tuesday, May 6th. The company reported $0.44 EPS for the quarter, beating the consensus estimate of $0.43 by $0.01. Fresenius Medical Care had a return on equity of 6.04% and a net margin of 3.43%. The business had revenue of $5.54 billion for the quarter, compared to the consensus estimate of $4.71 billion. As a group, analysts predict that Fresenius Medical Care AG will post 1.51 EPS for the current year.

Fresenius Medical Care Increases Dividend

The company also recently disclosed an annual dividend, which will be paid on Friday, June 6th. Investors of record on Friday, May 23rd will be paid a $0.7871 dividend. This is an increase from Fresenius Medical Care's previous annual dividend of $0.44. The ex-dividend date is Friday, May 23rd. This represents a yield of 1.9%. Fresenius Medical Care's dividend payout ratio is presently 49.11%.

Analyst Ratings Changes

A number of equities analysts have recently weighed in on the company. Wall Street Zen assumed coverage on Fresenius Medical Care in a research note on Tuesday. They issued a "strong-buy" rating on the stock. Morgan Stanley restated an "underweight" rating on shares of Fresenius Medical Care in a research note on Thursday, May 15th. Finally, Truist Financial boosted their target price on Fresenius Medical Care from $25.00 to $30.00 and gave the stock a "hold" rating in a research note on Monday, May 12th. One analyst has rated the stock with a sell rating, two have given a hold rating, one has issued a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat.com, the stock currently has an average rating of "Hold" and a consensus target price of $27.80.

Fresenius Medical Care Company Profile

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.